Association of IGF-1 and IGF-2 genotypes with respiratory muscle strength in individuals with COPD: A cross-sectional study
Medwave · 2024
DOI: 10.5867/medwave.2024.03.2783 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Medwave, 2024. Verfasst von Giovanna de Carvalho und 7 weiteren Autor:innen. Beteiligte Einrichtung: Program in Physiotherapy, Londrina State University (UEL), Paraná, Brazil. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Muscle Strength, Insulin-Like Growth Factor I, Respiratory Muscles. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Themen: COPD
Abstract (Originalsprache)
Introduction
Chronic obstructive pulmonary disease is a systemic disease characterized not only by respiratory symptoms but also by physical deconditioning and muscle weakness. One prominent manifestation of this disease is the decline in respiratory muscle strength. Previous studies have linked the genotypes of insulin-like growth factor 1 and 2 (IGF-1 and IGF-2) to muscle weakness in other populations without this disease. However, there is a notable knowledge gap regarding the biological mechanisms underlying respiratory muscle weakness, particularly the role of IGF-1 and IGF-2 genotypes in this pulmonary disease. Therefore, this study aimed to investigate, for the first time, the association between IGF-1 and IGF-2 genotypes with respiratory muscle strength in individuals with chronic obstructive pulmonary disease. In addition, we analyzed the relationship between oxidative stress, chronic inflammation, and vitamin D with respiratory muscle strength.
Methods
A cross sectional study with 61 individuals with chronic obstructive pulmonary disease. Polymerase chain reaction of gene polymorphisms IGF-1 (rs35767) and IGF-2 (rs3213221) was analyzed. Other variables, related to oxidative stress, inflammation and Vitamin D were dosed from peripheral blood. Maximal inspiratory and expiratory pressure were measured.
Results
The genetic polymorphisms were associated with respiratory muscle strength ( 3.0 and 3.5; = 0.57). Specific genotypes of IGF-1 and IGF-2 presented lower maximal inspiratory and expiratory pressure (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program in Physiotherapy, Londrina State University (UEL), Paraná, Brazil.
- Faculty of Health and Social Sciences, Universidad de Las Americas, Santiago, Chile.
- Program of Master and Doctoral degree in Rehabilitation Sciences, Londrina State University (UEL) and University North of Paraná (UNOPAR), Londrina, Brazil.
- Escuela de Fisioterapia, Universidad de las Americas, Quito, Ecuador.
- Departamento de Morfología, Facultad de Medicina, Universidad Andrés Bello, Santiago, Chile.
ORCID-Profile: Giovanna de Carvalho, Walter Sepúlveda-Loyola, Luana Oliveira de Lima, Stheace Kelly Fernandes Szezerbaty, Regina Célia Poli-Frederico, Héctor Gutiérrez-Espinoza, Juan José Valenzuela-Fuenzalida, Vanessa Suziane Probst
Zitieren
APA
de Carvalho, G., Sepúlveda-Loyola, W., Oliveira de Lima, L., Fernandes Szezerbaty, S. K., Poli-Frederico, R. C., Gutiérrez-Espinoza, H., Valenzuela-Fuenzalida, J. J., & Probst, V. S. (2024). Association of IGF-1 and IGF-2 genotypes with respiratory muscle strength in individuals with COPD: A cross-sectional study. Medwave. https://doi.org/10.5867/medwave.2024.03.2783
Vancouver
de Carvalho G, Sepúlveda-Loyola W, Oliveira de Lima L, Fernandes Szezerbaty SK, Poli-Frederico RC, Gutiérrez-Espinoza H, et al. Association of IGF-1 and IGF-2 genotypes with respiratory muscle strength in individuals with COPD: A cross-sectional study. Medwave. 2024. doi:10.5867/medwave.2024.03.2783
BibTeX
@article{deCarvalho2024,
author = {de Carvalho, Giovanna and Sepúlveda-Loyola, Walter and Oliveira de Lima, Luana and Fernandes Szezerbaty, Stheace Kelly and Poli-Frederico, Regina Célia and Gutiérrez-Espinoza, Héctor and Valenzuela-Fuenzalida, Juan José and Probst, Vanessa Suziane},
title = {Association of IGF-1 and IGF-2 genotypes with respiratory muscle strength in individuals with COPD: A cross-sectional study},
journal = {Medwave},
year = {2024},
doi = {10.5867/medwave.2024.03.2783}
}
EUVIMED